Add to ORKGContains fulltext : 20547.PDF (publisher's version ) (Open Access
International audiencePlatelet refractoriness is a serious complication for patients receiving recur...
Background and objectives: Antibodies (Ab) against HLA and HPA antigens play an important role in HC...
Loren D Fast Division of Hematology/Oncology, Rhode Island Hospital and Warren Alpert School of Medi...
Substitution of transfused platelet concentrates are often accused to cause HLA-antibody development...
Platelet transfusion refractoriness (PTR) is the major complication of long-term platelet supportive...
Despite significant advancements in the production of platelet products, storage, and transfusion, t...
Transfusion plays an important role in the management of patients with hematological malignancies a...
The effectiveness of platelet transfusions, an essential supportive care for mostly hemato-oncologic...
BACKGROUND: Platelet transfusions can induce alloimmunization against HLA antigens. The use of patho...
in a prospective study A red blood cell (RBC) transfusion is a large-scale intravenous introduction ...
BACKGROUNDCellular engraftment after allogeneic hematopoietic progenitor cell transplantation (HPCT)...
Contains fulltext : 4530.pdf (publisher's version ) (Open Access
BACKGROUND: The pathogenesis of posttransfusion purpura (PTP) and transfusion-associated graft-versu...
Leukocytes are known to have a number of biologic effects associated with allogeneic blood transfusi...
International audienceBackground: Patients with hematologic malignancies require prophylactic or cur...
International audiencePlatelet refractoriness is a serious complication for patients receiving recur...
Background and objectives: Antibodies (Ab) against HLA and HPA antigens play an important role in HC...
Loren D Fast Division of Hematology/Oncology, Rhode Island Hospital and Warren Alpert School of Medi...
Substitution of transfused platelet concentrates are often accused to cause HLA-antibody development...
Platelet transfusion refractoriness (PTR) is the major complication of long-term platelet supportive...
Despite significant advancements in the production of platelet products, storage, and transfusion, t...
Transfusion plays an important role in the management of patients with hematological malignancies a...
The effectiveness of platelet transfusions, an essential supportive care for mostly hemato-oncologic...
BACKGROUND: Platelet transfusions can induce alloimmunization against HLA antigens. The use of patho...
in a prospective study A red blood cell (RBC) transfusion is a large-scale intravenous introduction ...
BACKGROUNDCellular engraftment after allogeneic hematopoietic progenitor cell transplantation (HPCT)...
Contains fulltext : 4530.pdf (publisher's version ) (Open Access
BACKGROUND: The pathogenesis of posttransfusion purpura (PTP) and transfusion-associated graft-versu...
Leukocytes are known to have a number of biologic effects associated with allogeneic blood transfusi...
International audienceBackground: Patients with hematologic malignancies require prophylactic or cur...
International audiencePlatelet refractoriness is a serious complication for patients receiving recur...
Background and objectives: Antibodies (Ab) against HLA and HPA antigens play an important role in HC...
Loren D Fast Division of Hematology/Oncology, Rhode Island Hospital and Warren Alpert School of Medi...